Genocea Provides Second Quarter 2021 Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Genocea Biosciences (GNCA) Misses Q2 EPS by 2c
July 29, 2021 7:26 AM EDTGenocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.
... More